AZmed

• 21/02/2024
• Unknown
• $16,218,840

AZmed has been the first French company to commercialize AI-powered radiology software.

For the last 10 years, the number of medical imaging acts has been multiplied by 2 in OECD countries. In contrast, the number of specialists able to analyze this flow of information has stagnated. Thus, radiologists have less and less time to make the right decision and less time with the patient themselves. 


AZmed facilitates trauma and chest X-ray diagnostics thanks to artificial intelligence. It helps doctors save time and dedicate resources to life-threatening exams.

Deep learning technologies as developed by AZmed are fully integrated into doctors’ workflow, making them easy to use, without requiring any change in their work habits. We differentiate by focusing on low-level exams, to enable doctors to improve their daily productivity and optimize their workflows.

AZmed solutions are already used in more than 1000 healthcare institutions. More than 9000 doctors use the solution daily in 40 countries and 5 continents.


AZmed’s teams are working side by side with radiologists to shape the future of medical imaging.

Rayvolve is CE-marked IIa (under MDR 2017/45) and FDA-cleared.

---

---